Table 3.
KEGG pathway enrichment analysis.
| Description | Gene ratio | Bg Ratio | p value | p. adjust | q value |
|---|---|---|---|---|---|
| TNF signaling pathway | 18/79 | 112/8033 | 1.33E−17 | 7.30E−16 | 3.01E−16 |
| NF-kappa B signaling pathway | 9/79 | 104/8033 | 6.99E−07 | 3.03E−06 | 1.25E−06 |
| Toll-like receptor signaling pathway | 16/79 | 104/8033 | 2.10E−15 | 7.13E−14 | 2.95E−14 |
| Inflammatory bowel disease (IBD) | 13/79 | 65/8033 | 3.15E−14 | 8.03E−13 | 3.32E−13 |
| Cytokine-cytokine receptor interaction | 18/79 | 294/8033 | 3.03E−10 | 3.25E−09 | 1.34E−09 |
| Chemokine signaling pathway | 14/79 | 189/8033 | 3.21E−09 | 2.52E−08 | 1.04E−08 |
| T cell receptor signaling pathway | 11/79 | 104/8033 | 4.35E−09 | 3.17E−08 | 1.31E−08 |
| MAPK signaling pathway | 15/79 | 294/8033 | 1.29E−07 | 7.31E−07 | 3.02E−07 |
| PI3K-Akt signaling pathway | 16/79 | 354/8033 | 2.46E−07 | 1.25E−06 | 5.17E−07 |
| VEGF signaling pathway | 5/79 | 59/8033 | 2.67E−04 | 6.9E−04 | 2.8E−04 |